To include your compound in the COVID-19 Resource Center, submit it here.

Boehringer, Lilly, Geisinger partner to develop T2D risk prediction model

Geisinger Health System (Danville, Pa.), Boehringer Ingelheim GmbH (Ingelheim, Germany), and Eli Lilly and Co. (NYSE:LLY) partnered to develop a

Read the full 206 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE